Novartis CEO sets aside $700 million to settle doctor bribery lawsuit
July 18, 2019 at 02:25 AM EDT
Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close the chapter on allegedly aggressive business practices that exposed it to litigation risks.